Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19

• Main Authors: Phyo K. Myint (Author), Ben Carter (Author), Fenella Barlow-Pay (Author), Roxanna Short (Author), Alice G. Einarsson (Author), Eilidh Bruce (Author), Kathryn McCarthy (Author), Alessia Verduri (Author), Jemima Collins (Author), James Hesford (Author), Frances Rickard (Author), Emma Mitchell (Author), Mark Holloway (Author), Aine McGovern (Author), Arturo Vilches-Moraga (Author), Philip Braude (Author), Lyndsay Pearce (Author), Michael Stechman (Author), Angeline Price (Author), Terence J. Quinn (Author), Enrico Clini (Author), Susan Moug (Author), Jonathan Hewitt (Author)
• Format: Book
• Published: SAGE Publishing, 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Whilst there is literature on the impact of SARS viruses in the severely immunosuppressed, less is known about the link between routine immunosuppressant use and outcome in COVID-19. Consequently, guidelines on their use vary depending on specific patient populations. Methods: The study...